Diagnostic value of event-related evoked potentials N200 and P300 subcomponents in early diagnosis of Alzheimer's disease and mild cognitive impairment

Journal of Clinical Neurophysiology

Volumn 24, Issue 5, 2007, Pages 405-412

  Bennys, Karim ^a,b   Portet, Florence ^a   Touchon, Jacques ^a   Rondouin, Gérard ^a  

^a MONTPELLIER UNIVERSITY HOSPITAL   (France)

^b GUI DE CHAULIAC HOSPITAL   (France)

Author keywords

Aging; Alzheimer's disease; Event related evoked potentials; Mild cognitive impairment

Indexed keywords

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL TRIAL; COGNITIVE DEFECT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE SEVERITY; EARLY DIAGNOSIS; EVENT RELATED POTENTIAL; FEMALE; FUNCTIONAL ASSESSMENT; HUMAN; LATENT PERIOD; MALE; NEUROIMAGING; NEUROLOGIC EXAMINATION; NEUROPSYCHOLOGICAL TEST; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; STATISTICAL ANALYSIS;

AGED; ALZHEIMER DISEASE; COGNITION DISORDERS; ELECTROENCEPHALOGRAPHY; EVENT-RELATED POTENTIALS, P300; EVOKED POTENTIALS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 34948863343     PISSN: 07360258     EISSN: None     Source Type: Journal    
DOI: 10.1097/WNP.0b013e31815068d5     Document Type: Article

References (42)

1. Artero S, Ritchie K. The detection of mild cognitive impairment in the general practice setting. Aging Ment Health 2003;7:251-258.
2. Baddeley AD, Baddeley HA, Bucks RS, Wilcock GK. Attentional control in Alzheimer's disease. Brain 2001;124:1479-1481.
3. Blacker D, Albert MS, Basset SS, et al. Reliability and validity of NINCDS-ADRDA criteria for Alzheimer's disease. Arch Neurol 1994;51:1198-1204.
4. Blackwood DH, St Clair DM, Muir WJ, et al. The development of Alzheimer's disease in Down's syndrome assessed by auditory event-related potentials. J Ment Defic Res 1988;32:439-453.
5. Bokura H, Yamaguchi S, Kobayashi S. Event-related potentials for response inhibition in Parkinson's disease. Neuropsychologia 2005;43:965-975.
6. Borroni B, Anchisi D, Paghera B, et al. Combined 99mTc-ECD SPECT and neuropsychological studies in MCI for the assessment of conversion to AD. Neurobiol Aging 2006;27:24-31.
7. Boutros N, Torello MW, Burns EM, et al. Evoked potentials in subjects at risk for Alzheimer's disease. Psychiatry Res 1995;57:57-63.
8. Brandeis D, Lehmann D. Event-related potentials of the brain and cognitive processes: approaches and applications. Neuropsychologya 1986;24:151-168.
9. Diagnostic and Statistic Manual of Mental Disorders, DSM-IV, 4th edition. Washington: American Psychiatric Association, 1994.
10. Fernandez-Lastra A, Morales-Rodriguez M, Penzol-Diaz J. Neurophysiological study and use of P300 evoked potentials for investigation in the diagnosis and of follow-up of patients with Alzheimer's disease. Rev Neurol 2001;32:525-528.
11. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
12. Frodl T, Hampel H, Juckel G, et al. Value of event related P300 subcomponents in the clinical diagnosis of mild cognitive impairment and Alzheimer's disease. Psychophysiology 2002;39:175-181.
13. Gauthier S, Touchon J. Mild cognitive impairment is not a clinical entity and should not be treated. Arch Neurol 2005;62:1164-1166.
14. Gironell A, Garcia-Sanchez C, Estevez-Gonzalez A, et al. Usefulness of p300 in subjective memory complaints: a prospective study. J Clin Neurophysiol 2005;22:279-284.
15. Golebiowski M, Barcikowska M, Pfeffer A. Magnetic resonance imaging-based hippocampal volumetry in patients with dementia of the Alzheimer type. Dement Geriatr Cogn Disord 1992;10:284-288.
16. Golden JC. Identification of brain disorders by the Stroop color and word test. J Clin Psychol 1976;32:654-658.
17. Golob EJ, Johnson JK, Starr A. Auditory event-related potentials during target detection are abnormal in mild cognitive impairment. Clin Neurophysiol 2002;113:151-161.
18. Goodin DS, Squires KC, Starr A. Long latency event-related components of the auditory evoked potential in dementia. Brain 1978;101:635-648.
19. Goodin DS, Aminoff MJ. The distinction between different types of dementia using evoked potentials. In: Johnson R, Rohrbaugh JW, Parasuraman R, Eds. Current trends in event-related potential research. Electroencephalogr Clin Neurophysiol 1987:83:695-698.
20. Hampel H, Teipel SJ, Fuchsberger T, et al. Value of CSF beta-amyloid1-42 and tau as predictors of Alzheimer's disease in patients with mild cognitive impairment. Psychiatry. 2004;9:705-710.
21. Hansenne M. The p300 cognitive event-related potential. I. Theoretical and psychobiologic perspectives. Neurophysiol Clin 2000;30:191-210.
22. Hansenne M. The p300 cognitive event-related potential, II: Individual variability and clinical application in psychopathology. Neurophysiol Clin 2000;30:211-231.
23. Kalaft M, Hugonot-Diener L, Poitrenaud J. Etalonnage français du MMS version GRECO. Rev de Neuropsychol 2003;13:209-236.
24. Kindermann SS, Kalayam B, Brown GG, et al. Executive functions and P300 latency in elderly depressed patients and control subjects. Am J Geriatr Psychiatry 2000;8:57-65.
25. Laakso MP, Soininen H, Partanen K, et al. MRI of the hippocampus in Alzheimer's disease: Sensitivity, specificity and incorrectly classified subjects. Neurobiol Aging 1998;19:23-31.
26. Mattis S. Dementia Rating Scale: Professional Manual. Odessa, FC: Psychological Assessment Resources 1988.
27. McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: A report of NINCDS-ADRDA work group under auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984;34:939-944.
28. Pellet J, Decrat M, Lang F, et al. Description of a sample of 300 MADRS scales on depressive patients. Ann Med Psychol (Paris). 1987;145:170-175.
29. Petersen RC, Smith GE, Waring SC, et al. Aging, memory, and mild cognitive impairment. Int Psychogeriatr 1997;9:65-69.
30. Petersen RC, Smith GE, Waring SC, et al. Mild cognitive impairment: Clinical characterization and outcome. Arch Neurol 1999;56:303-308.
31. Petersen RC. Mild cognitive Impairment as a diagnostic entity. J Intern Med 2004;256:183-194.
32. Pfefferbaum A, Ford JM, Wenegrat BG, et al. Clinical application of the P3 component of event-related potentials, II: Dementia, depression and schizophrenia. Electroencephalogr Clin Neurophysiol 1984;59:104-124.
33. Polich J, Criado JR. Neuropsychology and neuropharmacology of P3a and P3b. Int J Psychophysiol 2006;60:172-185.
34. Portet F, Ousset PJ, Visser PJ, et al. Mild cognitive impairment in medical practice: critical review of the concept and new diagnostic procedure: Report of the MCI working group of the European Consortium on Alzheimer's disease (EADC). J Neurol Neurosurg Psychiatry published online 2006 Mar 20.
35. Portin R, Kovala T, Polo-Kantola P, et al. Does P3 reflect attentional or memory performances, or cognition more generally? Scand J Psychol 2000;41:31-40.
36. Reitan RM, Wolfson D. The Halstead-Reitan Neuropsychological Test Battery. Tuscon AZ: Neuropsychology Press 1985.
37. Sebastian MV, Menor J, Elosua MR. Attentional dysfunction of the central executive in AD: Evidence from dual task and perseveration errors. Cortex. 2006;42:1015-1020.
38. Slachevsky A, Villalpando JM, Sarazin M, et al. Frontal assessment battery and differential diagnosis of frontotemporal dementia and Alzheimer disease. Arch Neurol 2004;61:1104-1107.
39. Sutton S, Braren M, Zubin J, Johnn ER. Evoked potentials correlates of stimulus uncertainty. Science 1965;150:1187-1188.
40. Swanwick GR, Rowan MJ, Coen RF, et al. Prognostic value of electrophysiological markers in Alzheimer's disease. Am J Geriatr Psychiatry 1999;7 4-8.
41. Van Der Linden M, Colette F, Poitrenaud J, et al. L'épreuve de rappel libre/rappel indicé à 16 items (RL/RI-16). In: l'évaluation des troubles de la mémoire: Eds. Solal Marseille 2004.
42. Winblad B, Palmer K, Kivipelto M, et al. Mild cognitive impairment beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Inter Med 2004;256:240-246.